Abstract:Objective To study the clinical characteristics of patients undergoing implanted cardioverter defibrillator (ICD) implantation for primary prevention (PP) and secondary prevention (SP) of sudden cardiac death (SCD).Methods Patients undergoing implantation of ICD or cardiac resynchronization therapy with defibrillator function ( CRT-D ) during 2006 to 2011 were consecutively recruited,of whom clinical data were collected.Change in the quantity of total implantations as well as proportion of PP implantations through years were calculated,and clinical characteristics of patients were compared between PP and SP groups.Results A total of 214 patients were enrolled,including 108 for PP and 106 for SP.Both the total number of implantations and proportion of SP implantations increased over the years.Patients of PP suffer worse NYHA class ( P＜0.01 ),lower left ventricular ejection fraction[ (0.34±0.10) vs.(0.50±0.16),P＜0.01 ],more widened QRSduration [ ( 135.83±35.08 ) ms vs.( 111.68 ±34.15 ) ms,P＜0.01 ],higher level of log (NT-proBNP) [ (3.32±0.62 ) pg/ml vs.(2.83 ±0.83 ) pg/ml,P＜0.01 ],and lower glomerular filtration rate [ ( 75.15±24.23 ) ml/min vs.( 90.25 ± 70.30 ) ml/min,P =0.037 ].Constitution of primary heart diseases was significantly different between PP as SP groups( P＜0.01 ),with low proportion of coronary heart disease in both groups( 13.1％ and 22.6％ ).Most patients of SP received single-chamber ICD(84.0％ ),while most PP patients received CRT-D (74.1％ ),given significant difference between groups ( P＜0.01 ).Conclusion With the increase in quantity of total implantations and proportion of PP implantations,PP patient screening deserves more attention,especially those of left ventricular dysfunction after myocardial infarction and without indication for cardiac resynchronization therapy.

Clinical characteristics of patients undergoing cardioverter defibrillator implantation for primary and secondary prevention of sudden cardiac death